Stocks and Investing Stocks and Investing
Tue, November 10, 2020
Mon, November 9, 2020
Fri, November 6, 2020

David Lebovitz Maintained (ALNY) at Buy with Increased Target to $200 on, Nov 6th, 2020


Published on 2024-10-27 14:41:27 - WOPRAI, David Lebovitz
  Print publication without navigation


David Lebovitz of Morgan Stanley, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $197 to $200 on, Nov 6th, 2020.

David has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold and Decreased Target to $156 on, Tuesday, August 11th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $90 on, Friday, August 7th, 2020


This is the rating of the analyst that currently disagrees with David


  • Joel Beatty of "Citigroup" Initiated at Strong Buy and Held Target at $170 on, Tuesday, September 8th, 2020